Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

被引:27
|
作者
Tomii, Yasuhiro [1 ]
Toyoda, Kazunori [1 ]
Nakashima, Takahiro [1 ]
Nezu, Tomohisa [1 ]
Koga, Masatoshi [2 ]
Yokota, Chiaki [1 ]
Nagatsuka, Kazuyuki [3 ]
Minematsu, Kazuo [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan
基金
日本学术振兴会;
关键词
blood pressure; heart rate; hypertension; outcome; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; SAFE IMPLEMENTATION; PROGNOSTIC-SIGNIFICANCE; DIFFERENT SUBTYPES; CLINICAL-TRIAL; THROMBOLYSIS; ALTEPLASE; ASSOCIATION; VARIABILITY; PREDICTORS;
D O I
10.1097/HJH.0b013e32834a764e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and purpose The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles. Methods We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h. Results Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH. Conclusion Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months. J Hypertens 29:1980-1987 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1980 / 1987
页数:8
相关论文
共 50 条
  • [41] Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review
    Bhatt, Archit
    Safdar, Adnan
    Chaudhari, Dhara
    Clark, Diane
    Pollak, Amber
    Majid, Arshad
    Kassab, Mounzer
    STROKE RESEARCH AND TREATMENT, 2013, 2013
  • [42] Utilization of Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Are There Sex Differences?
    Allen, Norrina B.
    Myers, Daniela
    Watanabe, Emi
    Dostal, Jackie
    Sama, Danny
    Goldstein, Larry B.
    Lichtman, Judith H.
    CEREBROVASCULAR DISEASES, 2009, 27 (03) : 254 - 258
  • [43] Rehabilitation Outcomes of Stroke Patients Treated With Tissue Plasminogen Activator
    Meiner, Zeev
    Sajin, Anna
    Schwartz, Isabella
    Tsenter, Jeanna
    Yovchev, Ivelin
    Eichel, Roni
    Ben-Hur, Tamir
    Leker, Ronen R.
    PM&R, 2010, 2 (08) : 698 - 702
  • [44] Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator
    Betts, Keith A.
    Hurley, Dana
    Song, Jinlin
    Sajeev, Gautam
    Guo, Jenny
    Du, Ella Xiaoyan
    Paschoalin, Marco
    Wu, Eric Q.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (09): : 1996 - 2003
  • [45] Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
    Huang Yin-hui
    Zhuo Shi-tu
    Chen Ya-fang
    Li Ming-mei
    Lin You-yu
    Yang Mei-li
    Chen Zhen-jie
    Cai Ruo-wei
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4685 - 4690
  • [46] Racial and Ethnic Disparities in the Use of Intravenous Recombinant Tissue Plasminogen Activator and Outcomes for Acute Ischemic Stroke
    Nasr, Deena M.
    Brinjikji, Waleed
    Cloft, Harry J.
    Rabinstein, Alejandro A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (02): : 154 - 160
  • [47] Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
    HUANG Yin-hui
    ZHUO Shi-tu
    CHEN Ya-fang
    LI Ming-mei
    LIN You-yu
    YANG Mei-li
    CHEN Zhen-jie
    CAI Ruo-wei
    中华医学杂志(英文版), 2013, 126 (24) : 4685 - 4690
  • [48] Outcomes of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 90 Years or Older
    Mateen, Farrah J.
    Nasser, Majeed
    Spencer, Byron R.
    Freeman, William D.
    Shuaib, Ashfaq
    Demaerschalk, Bart M.
    Wijdicks, Eelco F. M.
    MAYO CLINIC PROCEEDINGS, 2009, 84 (04) : 334 - 338
  • [49] Outcomes following intravenous tissue-plasminogen activator (IV TPA) on a Canadian stroke unit.
    Jarrett, J
    Gubitz, G
    Phillips, S
    STROKE, 2000, 31 (11) : 2883 - 2883
  • [50] Endovascular Thrombectomy for Acute Ischemic Stroke in Failed Intravenous Tissue Plasminogen Activator Versus Non-Intravenous Tissue Plasminogen Activator Patients Revascularization and Outcomes Stratified by the Site of Arterial Occlusions
    Shi, Zhong-Song
    Loh, Yince
    Walker, Gary
    Duckwiler, Gary R.
    STROKE, 2010, 41 (06) : 1185 - 1192